PCVX - Vaxcyte, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$89.00
DETAILS
HIGH:
$89.00
LOW:
$89.00
MEDIAN:
$89.00
CONSENSUS:
$89.00
UPSIDE:
88.16%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 1.4 | 1.2 | 1.0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (1.4) | (1.2) | (1.0) | 0 |
| Operating Expenses | |||||||||
| R&D Expenses | 794.3 | 476.6 | 332.3 | 169.5 | 78.4 | 73.6 | 45.6 | 30.1 | 12.8 |
| SG&A Expenses | 129.4 | 92.9 | 60.7 | 39.8 | 25.3 | 14.6 | 7.3 | 5.4 | 5.0 |
| Other Expenses | 0 | 0 | 75 | 23.0 | 0 | 0 | 0 | 5.2 | 0 |
| Operating Expenses | 923.7 | 569.5 | 468.0 | 232.3 | 103.7 | 88.2 | 52.9 | 35.5 | 17.4 |
| Operating Income | |||||||||
| Operating Income | (923.7) | (569.5) | (468.0) | (232.3) | (103.7) | (89.6) | (54.2) | (35.5) | (17.8) |
| Interest Expense | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0 |
| Interest Income | 119.7 | 110.0 | 62.9 | 8.4 | 0.3 | 0.2 | 0.6 | 0.9 | 0.2 |
| Profitability | |||||||||
| EBITDA | (741.8) | (448.1) | (392.1) | (214.0) | (96.6) | (87.8) | (49.0) | (28.4) | (17.2) |
| EBIT | (766.6) | (463.9) | (402.3) | (223.5) | (100.1) | (89.2) | (50.2) | (29.4) | (17.8) |
| Income Before Tax | (766.6) | (463.9) | (402.3) | (223.5) | (100.1) | (89.2) | (50.3) | (29.5) | (17.2) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (766.6) | (463.9) | (402.3) | (223.5) | (100.1) | (89.2) | (50.3) | (29.5) | (17.2) |
| Per Share Data | |||||||||
| EPS (Basic) | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -2.97 | -14.10 | -8.12 | -4.84 |
| EPS (Diluted) | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -2.97 | -14.10 | -8.12 | -4.83 |
| Shares Outstanding | 136.1 | 122.0 | 97.2 | 64.9 | 51.9 | 29.5 | 3.8 | 3.6 | 3.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 174.0 | 387.9 | 397.5 | 834.7 | 69.0 | 386.2 | 59.0 | 66.1 | 36.1 |
| Short-Term Investments | 1,387 | 1,359.3 | 682.8 | 96.7 | 177.0 | 0 | 0 | 0 | 0 |
| Net Receivables | 46.6 | 20.7 | 3.6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.8 | 20.1 | 6.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 1,627.4 | 1,788.0 | 1,096.0 | 942.6 | 256.3 | 389.0 | 61.7 | 66.7 | 36.3 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 491.7 | 270.1 | 110.6 | 31.6 | 35.9 | 3.3 | 3.4 | 3.4 | 3.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 883.1 | 1,387.5 | 162.7 | 26.5 | 27.1 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.5 | 65.7 | 38.7 | 5.4 | 5.0 | 0.6 | 0.6 | 0.7 | 0.3 |
| Total Non-Current Assets | 1,418.6 | 1,723.3 | 312.0 | 63.6 | 68.0 | 3.8 | 4.0 | 4.1 | 3.3 |
| Total Assets | 3,046.0 | 3,511.3 | 1,407.9 | 1,006.2 | 324.3 | 392.8 | 65.7 | 70.8 | 39.6 |
| Current Liabilities | |||||||||
| Account Payables | 70.9 | 48.5 | 14.6 | 9.8 | 6.8 | 29.8 | 3.4 | 2.8 | 1.8 |
| Short-Term Debt | 6.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.3) | 0 |
| Other Current Liabilities | 105.7 | 20.6 | 11.1 | 1.2 | 3.5 | 0.3 | 0.4 | 2.4 | 0.8 |
| Total Current Liabilities | 205.8 | 140.2 | 145.3 | 40.5 | 28.7 | 46.9 | 11.1 | 6.7 | 4.3 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 111.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.8 |
| Deferred Tax Liabilities | 43.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (111.3) | 0.1 | 0 | 0.0 | 0.1 | 0.1 | 161.0 | 121.7 | 0.2 |
| Total Non-Current Liabilities | 154.7 | 65.3 | 22.1 | 12.0 | 11.6 | 0.1 | 161.0 | 121.8 | 4.4 |
| Total Liabilities | 360.5 | 205.5 | 167.4 | 52.6 | 40.3 | 47.0 | 172.1 | 128.5 | 8.7 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (2,154.9) | (1,388.3) | (924.4) | (522.1) | (298.6) | (198.6) | (109.3) | (59.1) | (29.6) |
| Accumulated Other Comprehensive Income | 1.6 | (3.9) | 0.2 | (0.4) | (0.2) | 0 | 0 | (1.8) | 0 |
| Total Stockholders' Equity | 2,685.5 | 3,305.8 | 1,240.5 | 953.6 | 284.0 | 345.8 | (106.4) | (57.7) | 30.9 |
| Total Liabilities & Equity | 3,046.0 | 3,511.3 | 1,407.9 | 1,006.2 | 324.3 | 392.8 | 65.7 | 70.8 | 39.6 |
| Debt Metrics | |||||||||
| Total Debt | 228.8 | 71.1 | 29.2 | 17.9 | 16.8 | 0 | 0.2 | 0.5 | 4.5 |
| Net Debt | 54.9 | (316.8) | (368.2) | (816.7) | (52.2) | (386.2) | (58.8) | (65.6) | (31.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | (766.6) | (463.9) | (402.3) | (223.5) | (100.1) | (89.2) | (50.3) | (29.5) | (0.0) |
| Depreciation & Amortization | 24.9 | 15.8 | 10.2 | 9.5 | 3.5 | 1.4 | 1.2 | 1.0 | 0.0 |
| Stock-Based Compensation | 138.8 | 84.8 | 48.8 | 23.6 | 10.7 | 5.4 | 1.2 | 0.7 | 0.0 |
| Change in Working Capital | 19.9 | (54.9) | 81.3 | 12.7 | (37.0) | 35.3 | 3.9 | 1.9 | 0.0 |
| Other Non-Cash Items | (72.6) | (34.5) | (34.8) | 7.0 | 1.5 | 0.2 | (3.2) | (4.7) | 0.0 |
| Operating Cash Flow | (655.6) | (452.6) | (296.8) | (170.6) | (121.4) | (46.6) | (47.1) | (30.5) | (0.0) |
| Investing Activities | |||||||||
| Capital Expenditure | (13.7) | (22.4) | (67.9) | (5.8) | (6.6) | (1.2) | (1.2) | (1.8) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.0 | 0 |
| Purchases of Investments | (1,211.5) | (3,086.7) | (1,329.9) | (102.7) | (336.3) | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 1,705.8 | 1,200.2 | 624.5 | 183.2 | 130.6 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (43.3) | (96.7) | 0 | 0 | 0.0 | 0 | 0 | 0.0 | 0.0 |
| Investing Cash Flow | 437.4 | (2,005.7) | (773.3) | 74.6 | (212.3) | (1.1) | (1.2) | (1.8) | (0.0) |
| Financing Activities | |||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.3) | (0.3) | (0.2) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.0 | 12.9 | 3.8 | 5.1 | 3.9 | 1.0 | (0.7) | 0.1 | 0.2 |
| Financing Cash Flow | 2.0 | 2,448.5 | 639.8 | 861.5 | 17.8 | 374.9 | 41.6 | 62.2 | 0.0 |
| Cash Position | |||||||||
| Net Change in Cash | (213.8) | (9.4) | (437.0) | 765.7 | (316.3) | 327.2 | (7.1) | 30.0 | 0.0 |
| Cash at Beginning | 389.2 | 398.6 | 835.5 | 69.9 | 386.2 | 59.0 | 66.1 | 36.1 | 0.0 |
| Cash at End | 175.4 | 389.2 | 398.6 | 835.5 | 69.9 | 386.2 | 59.0 | 66.1 | 0.0 |
| Free Cash Flow | (669.3) | (475.1) | (364.7) | (176.4) | (127.9) | (47.8) | (48.3) | (32.2) | (0.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | (1.4) | (1.2) | (1.0) | 0 |
| Operating Income | (923.7) | (569.5) | (468.0) | (232.3) | (103.7) | (89.6) | (54.2) | (35.5) | (17.8) |
| Net Income | (766.6) | (463.9) | (402.3) | (223.5) | (100.1) | (89.2) | (50.3) | (29.5) | (17.2) |
| EPS (Diluted) | -5.63 | -3.80 | -4.14 | -3.44 | -1.93 | -2.97 | -14.10 | -8.12 | -4.83 |
| Balance Sheet | |||||||||
| Cash & Equivalents | 174.0 | 387.9 | 397.5 | 834.7 | 69.0 | 386.2 | 59.0 | 66.1 | 36.1 |
| Total Assets | 3,046.0 | 3,511.3 | 1,407.9 | 1,006.2 | 324.3 | 392.8 | 65.7 | 70.8 | 39.6 |
| Total Debt | 228.8 | 71.1 | 29.2 | 17.9 | 16.8 | 0 | 0.2 | 0.5 | 4.5 |
| Stockholders' Equity | 2,685.5 | 3,305.8 | 1,240.5 | 953.6 | 284.0 | 345.8 | (106.4) | (57.7) | 30.9 |
| Cash Flow | |||||||||
| Operating Cash Flow | (655.6) | (452.6) | (296.8) | (170.6) | (121.4) | (46.6) | (47.1) | (30.5) | (0.0) |
| Capital Expenditure | (13.7) | (22.4) | (67.9) | (5.8) | (6.6) | (1.2) | (1.2) | (1.8) | (0.0) |
| Free Cash Flow | (669.3) | (475.1) | (364.7) | (176.4) | (127.9) | (47.8) | (48.3) | (32.2) | (0.0) |